Form 4: BioLife Solutions EVP Aby J. Mathew Sells Shares to Cover Tax Obligations

Aby J. Mathew, EVP & Chief Scientific Officer of BioLife Solutions Inc., sold 517 shares of common stock on May 29, 2024, to satisfy tax withholding obligations.

Summary

• On May 29, 2024, Aby J. Mathew, the EVP & Chief Scientific Officer of BioLife Solutions Inc. (BLFS), sold 517 shares of the company's common stock.
• The shares were sold at a price of $21.78 per share.
• The transaction was executed under a pre-arranged Rule 10b5-1(c) trading plan adopted on February 24, 2022.
• The purpose of the sale was to cover tax withholding obligations related to the vesting of restricted stock shares.
• Following the transaction, Mathew directly owns 318,483 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an insider stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Industry Context

Insider sales are a common occurrence in publicly traded companies, often related to executive compensation and personal financial planning. The use of Rule 10b5-1 plans allows insiders to sell shares at predetermined times to avoid accusations of trading on non-public information.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the pre-planned nature of the transaction mitigates this concern.

Key Dates